These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3600950)

  • 21. Age-related changes in the N-methyl-D-aspartate receptor binding sites within the human basal ganglia.
    Villares JC; Stavale JN
    Exp Neurol; 2001 Oct; 171(2):391-404. PubMed ID: 11573991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal dopamine receptors in Alzheimer-type dementia.
    Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Markakis D
    Neurosci Lett; 1984 Nov; 52(1-2):1-6. PubMed ID: 6241300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P; Boyson SJ; Reuter S; Molinoff PB
    Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation.
    Joyce JN; Loeschen SK; Marshall JF
    Brain Res; 1985 Jul; 338(2):209-18. PubMed ID: 3161583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
    Flaim KE; Gessner GW; Crooke ST; Sarau HM; Weinstock J
    Life Sci; 1985 Apr; 36(15):1427-36. PubMed ID: 2858801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain dopamine D-2 receptors in senile dementia.
    Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
    J Neural Transm; 1986; 65(1):51-62. PubMed ID: 2870131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in dopaminergic receptors in Huntington's disease.
    Reisine TD; Fields JZ; Stern LZ; Johnson PC; Bird ED; Yamamura HI
    Life Sci; 1977 Oct; 21(8):1123-8. PubMed ID: 144230
    [No Abstract]   [Full Text] [Related]  

  • 28. Striatal topography of D-2 receptors correlates with indexes of cholinergic neuron localization.
    Joyce JN; Marshall JF
    Neurosci Lett; 1985 Jan; 53(1):127-31. PubMed ID: 3157889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related changes in glutamate receptors: an autoradiographic analysis.
    Wardas J; Pietraszek M; Schulze G; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1997; 49(6):401-10. PubMed ID: 9566043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia.
    Carlsson A; Winblad B
    J Neural Transm; 1976; 38(3-4):271-6. PubMed ID: 956813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
    Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
    J Neurol Sci; 1988 Sep; 86(2-3):291-306. PubMed ID: 2975699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coactivation of dopamine D1 and D2 receptors increases the affinity of cholecystokinin-8 receptors in membranes from post-mortem human caudate-putamen.
    von Euler G; Mailleux P; von Euler M; Schiffmann SN; Vanderhaeghen JJ; Fuxe K
    Brain Res; 1992 Jul; 584(1-2):157-62. PubMed ID: 1325243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differences.
    Falardeau P; Di Paolo T
    Neurosci Lett; 1987 Feb; 74(1):43-8. PubMed ID: 2951620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM; Wooten GF; Trugman JM
    J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
    Wamsley JK; Gehlert DR; Filloux FM; Dawson TM
    J Chem Neuroanat; 1989; 2(3):119-37. PubMed ID: 2528968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biogenic amine-stimulated adenylate cyclase and spiroperidol-binding sites in rabbit brain: evidence for selective loss of receptors with aging.
    Makman MH; Ahn HS; Thal LJ; Dvorkin B; Horowitz SG; Sharpless NS; Rosenfeld M
    Adv Exp Med Biol; 1978; 113():211-30. PubMed ID: 753089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.